2-105361319-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001318895.3(FHL2):​c.804C>T​(p.Asp268=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 1,613,654 control chromosomes in the GnomAD database, including 10,367 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.087 ( 710 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9657 hom. )

Consequence

FHL2
NM_001318895.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.653
Variant links:
Genes affected
FHL2 (HGNC:3703): (four and a half LIM domains 2) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. This protein is thought to have a role in the assembly of extracellular membranes. Also, this gene is down-regulated during transformation of normal myoblasts to rhabdomyosarcoma cells and the encoded protein may function as a link between presenilin-2 and an intracellular signaling pathway. Multiple alternatively spliced variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 2-105361319-G-A is Benign according to our data. Variant chr2-105361319-G-A is described in ClinVar as [Benign]. Clinvar id is 48331.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-105361319-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.653 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FHL2NM_001318895.3 linkuse as main transcriptc.804C>T p.Asp268= synonymous_variant 7/7 ENST00000530340.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FHL2ENST00000530340.6 linkuse as main transcriptc.804C>T p.Asp268= synonymous_variant 7/71 NM_001318895.3 P1Q14192-1

Frequencies

GnomAD3 genomes
AF:
0.0866
AC:
13176
AN:
152116
Hom.:
710
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0257
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.108
Gnomad ASJ
AF:
0.0927
Gnomad EAS
AF:
0.0231
Gnomad SAS
AF:
0.0509
Gnomad FIN
AF:
0.0995
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.125
Gnomad OTH
AF:
0.0939
GnomAD3 exomes
AF:
0.0936
AC:
23481
AN:
250918
Hom.:
1246
AF XY:
0.0934
AC XY:
12675
AN XY:
135668
show subpopulations
Gnomad AFR exome
AF:
0.0228
Gnomad AMR exome
AF:
0.0998
Gnomad ASJ exome
AF:
0.0901
Gnomad EAS exome
AF:
0.0253
Gnomad SAS exome
AF:
0.0552
Gnomad FIN exome
AF:
0.0975
Gnomad NFE exome
AF:
0.122
Gnomad OTH exome
AF:
0.110
GnomAD4 exome
AF:
0.111
AC:
161934
AN:
1461420
Hom.:
9657
Cov.:
32
AF XY:
0.109
AC XY:
79500
AN XY:
727036
show subpopulations
Gnomad4 AFR exome
AF:
0.0230
Gnomad4 AMR exome
AF:
0.100
Gnomad4 ASJ exome
AF:
0.0896
Gnomad4 EAS exome
AF:
0.0207
Gnomad4 SAS exome
AF:
0.0548
Gnomad4 FIN exome
AF:
0.101
Gnomad4 NFE exome
AF:
0.123
Gnomad4 OTH exome
AF:
0.102
GnomAD4 genome
AF:
0.0866
AC:
13179
AN:
152234
Hom.:
710
Cov.:
32
AF XY:
0.0849
AC XY:
6318
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.0257
Gnomad4 AMR
AF:
0.108
Gnomad4 ASJ
AF:
0.0927
Gnomad4 EAS
AF:
0.0232
Gnomad4 SAS
AF:
0.0516
Gnomad4 FIN
AF:
0.0995
Gnomad4 NFE
AF:
0.125
Gnomad4 OTH
AF:
0.0929
Alfa
AF:
0.111
Hom.:
1286
Bravo
AF:
0.0849
Asia WGS
AF:
0.0320
AC:
110
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 16, 2012Asp268Asp in exon 6 of FHL2: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue, is not located within t he splice consensus sequence, and has been identified in 12% (868/7020) of Europ ean American chromosomes from a broad population by the NHLBI Exome Sequencing P roject (http://evs.gs.washington.edu/EVS; dbSNP rs3087523). -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxSep 06, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Primary dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.21
DANN
Benign
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3087523; hg19: chr2-105977776; COSMIC: COSV59079045; COSMIC: COSV59079045; API